US › Healthcare

China SXT Pharmaceuticals Inc (SXTC)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$0.12+60.08%

Last close · 2026-08-04

Latest quarter · ended 2026-06-30

Revenue

$1.2M

Revenue YoY

+163.0%

Net profit

$163,718

Profit YoY

+113.1%

EPS

$-0.05

EPS estimate

$0.00

Net margin

13.7%

Key statistics

Market cap

$2.4M

Forward P/E

0.0

P/B

0.08

Book value

$31.01

EPS (TTM)

$-9.13

52-week high

$312.00

52-week low

$0.05

50-day MA

$1.85

200-day MA

$67.31

Beta

1.82

Shareholding

Insiders

82.57%

Institutions

0.18%

Largest institutional holders

Fund	Stake
Sabby Management LLC	0.20%
Royal Bank of Canada	0.00%
Caitong International Asset Management Co., Limited.	0.00%
UBS Group AG	0.00%
Amvescap Plc.	0.00%
Geode Capital Management, LLC	0.00%
Tower Research Capital LLC	0.00%
Citadel Advisors Llc	0.00%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for China SXT Pharmaceuticals Inc — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.